Spectrum
Spectrum is a Nevada-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model:
Revenue: $10.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Spectrum Information
Geographic Data
Address: 2 Atlantic Avenue,
City: Boston
State: MA
Zip: 02110
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$20M
Raised Total:$123M
Social
Metrics
2,671,369Website Global Rank
6,279Website Monthly Traffic
Twitter Followers
Description
Spectrum is a Nevada-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Contact Phone:
+16175863900
Contact Email:
Spectrum went public on 10/4/1996 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/4/1996
Ticker Symbol:
SPPI
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Post-IPO Debt | $30M |
SLR Capital Partners, LLC |
7/2013 | Equity | $27.5M | 9/2022 | Post-IPO Debt | 1 | $30M |
SLR Capital Partners SLR Capital Partners |
1/2022 | Post-IPO Equity | $0 |
Hanmi Pharmaceutical Hanmi Pharmaceutical |
5/2008 | Post-IPO Equity | $0 |
Par Pharmaceuticals Par Pharmaceuticals |
5/2007 | Post-IPO Equity | $0 |
Perceptive Advisors Federated Kaufmann Fund SDS Capital Group Perceptive Advisors Federated Kaufmann Fund SDS Capital Group |
11/2010 | Grant | $977.9k | 4/2016 | Post-IPO Equity | $3M | 7/2020 | Post-IPO Equity | $65M | 9/2005 | Post-IPO Equity | $42M | 4/2004 | Post-IPO Equity | $25M | 1/2022 | Corporate Round | 1 | $20M |
Hanmi Pharmaceutical Hanmi Pharmaceutical |
5/2008 | Post-IPO Equity | 1 | $20M |
Par Pharmaceuticals Par Pharmaceuticals Par Pharmaceuticals Par Pharmaceuticals |
5/2007 | Post-IPO Equity | 3 | $30M |
Perceptive Advisors Federated Kaufmann Fund SDS Capital Group Perceptive Advisors Federated Kaufmann Fund SDS Capital Group |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2013 | TALON THERAPEUTICS | |
| 9/2012 | Allos Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
